Ryan Specialty Group (RYAN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
2 Aug, 2026Executive summary
Total revenue for Q2 2026 grew 7.2% to $916.6 million, driven by 6.7% organic growth, M&A, and strong client retention.
Adjusted EBITDA/EBITDAC increased 6% to $327 million, with margin improving to 35.7%; adjusted EPS rose 12.1% to $0.74.
Net income declined 13.1% year-over-year to $108.4 million due to higher expenses and restructuring costs.
$284.5 million was returned to shareholders via $260 million in share repurchases and $24.5 million in dividends/distributions; buyback authorization expanded by $300 million.
Investments in digital transformation, AI, and talent are accelerating productivity and operational efficiency.
Financial highlights
Adjusted EBITDA/EBITDAC margin was 35.7%, down 40 basis points year-over-year.
Adjusted net income margin reached 21.7%; net income margin was 11.8%.
Compensation and benefits expense ratio was 58.0%, with adjusted ratio at 54.0%.
General and administrative expense ratio was 12.9%, with adjusted ratio at 10.3%.
For the first half of 2026, organic revenue grew 8.9%, adjusted EBITDA 9.8%, and adjusted EPS 16.2%.
Outlook and guidance
Organic revenue growth for 2026 is expected at the higher end of mid-single digits.
Full-year adjusted EBITDA/EBITDAC margin is guided to decline by 50–100 basis points year-over-year.
Empower Program targets $80 million in annual savings by 2029, with $160 million in cumulative one-time charges through 2028.
Guidance reflects continued property pricing declines, heightened competition, and moderate decline in the property book.
No meaningful M&A expected to close in 2026; focus shifts to 2027.
Latest events from Ryan Specialty Group
- Industry leader in specialty insurance, driving growth through innovation, scale, and M&A.RYAN
Investor presentation - Scale, innovation, and disciplined growth drive resilience and leadership in specialty insurance.RYAN
46th Annual William Blair Growth Stock Conference - Revenue up 15.2% to $795.2M, organic growth 11.8%, net income $40.6M, margin pressure ahead.RYAN
Q1 2026 - Record revenue, expanded shareholder rights, and a focus on performance-based leadership mark 2025.RYAN
Proxy Filing - Shareholders will vote on director elections, auditor ratification, and executive pay approval.RYAN
Proxy Filing - 2025 revenue up 21.3% to $3.1B, with 10.1% organic growth and $300M buyback authorized.RYAN
Q4 2025 - Revenue up 18.8% and net income up 40.8%, with margin and guidance both raised.RYAN
Q2 2024 - Q3 revenue up 20.5%, net income up 82.4%, and adjusted EBITDAC up 29.4% year-over-year.RYAN
Q3 2024 - Revenue up 25% and adjusted EBITDAC up 27.5%, but net income impacted by non-cash tax expense.RYAN
Q1 2025